The anti-angiogenic activity of the selective cyclooxygenase-2 inhibitor rofecoxib on colorectal cancer liver metastases

Lead Research Organisation: University of Leeds
Department Name: Unknown

Abstract

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
 
Description Dr Woltering (Dept of Surgical Endocrinology, Louisiana State University, New Orleans, USA) 
Organisation Louisiana State University
Department Surgical Endocrinology/Oncology
Country United States 
Sector Academic/University 
PI Contribution NA
Collaborator Contribution obtained information and reagents from Dr Woltering
Impact NA
 
Description Hepatobiliary, Medical Physics and Radiology Units at St James's University Hospital 
Organisation St James's University Hospital (Jimmy's)
Department Hepatobiliary, Medical Physics and Radiology Units
Country United Kingdom 
Sector Public 
PI Contribution NA
Collaborator Contribution access to patients undergoing assessment and treatment for CRC liver metastases and to facilities such as fresh specimen collection and dynamic contrast-enhanced MRI scanning. The Cancer Research UK Clinical Research Centre on campus provided access to resources including radio-isotope measurement.
Impact NA
 
Description Professor Tai (Dept of Pharmaceutical Sciences, University of Kentucky, Lexington, KY, USA). 
Organisation University of Kentucky
Country United States 
Sector Academic/University 
PI Contribution NA
Collaborator Contribution obtained information and reagents from Professor Tai
Impact NA